FBIO Fortress Biotech, Inc.
Healthcare · Market cap: not available
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $143.6K | $0 |
| 2023-Q1 | $3.3M | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $28.0K | $0 |
| 2023-Q4 | $2.9M | $0 |
| 2024-Q1 | $119.0K | $0 |
| 2024-Q2 | $50.4K | $18.9K |
| 2024-Q3 | $1.4M | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$8.0M17 buy days
Sold$31.2K2 sell days
Net insider flow+$7.9Mnet buying · 5 years
Latest trade2024-09-23ROSENWALD LINDSAY A MD
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2024-09-23 | Buy | ROSENWALD LINDSAY A MD | CEO | 763,359 | $1.84 | $1.4M | 1 |
| 2024-06-28 | Buy | ROSENWALD LINDSAY A MD | CEO | 20,000 | $1.64 | $32.8K | 1 |
| 2024-05-20 | Sell | Klein Dov | Director | 10,000 | $1.89 | $18.9K | 1 |
| 2024-05-16 | Buy | ROSENWALD LINDSAY A MD | CEO | 10,000 | $1.76 | $17.6K | 1 |
| 2024-01-05 | Buy | ROSENWALD LINDSAY A MD | CEO | 50,000 | $2.38 | $119.0K | 1 |
| 2023-11-14 | Buy | ROSENWALD LINDSAY A MD | CEO | 1,567,515 | $1.70 | $2.7M | 1 |
| 2023-11-14 | Buy | WEISS MICHAEL S | Director | 147,058 | $1.70 | $250.0K | 1 |
| 2023-09-26 | Buy | ROSENWALD LINDSAY A MD | CEO | 100,000 | $0.28 | $28.0K | 1 |
| 2023-02-10 | Buy | ROSENWALD LINDSAY A MD | CEO | 2,395,209 | $0.84 | $2.0M | 1 |
| 2023-02-10 | Buy | WEISS MICHAEL S | Director | 1,197,604 | $0.84 | $1.0M | 1 |
| 2023-02-10 | Buy | LOBELL J JAY | Director | 299,401 | $0.84 | $251.5K | 1 |
| 2023-02-10 | Buy | Jin David | CFO | 35,928 | $0.84 | $30.2K | 1 |
| 2023-02-10 | Buy | Rowinsky Eric K | Director | 11,976 | $0.84 | $10.1K | 1 |
| 2023-02-10 | Buy | Lu Lucy | Director | 11,976 | $0.84 | $10.1K | 1 |
| 2022-12-01 | Buy | ROSENWALD LINDSAY A MD | CEO | 100,000 | $0.68 | $68.0K | 1 |
| 2022-11-30 | Buy | ROSENWALD LINDSAY A MD | CEO | 5,000 | $0.56 | $2.8K | 1 |
| 2022-11-30 | Buy | Jin David | CFO | 5,000 | $0.56 | $2.8K | 1 |
| 2022-10-21 | Buy | ROSENWALD LINDSAY A MD | CEO | 100,000 | $0.70 | $70.0K | 1 |
| 2021-12-28 | Sell | Klein Dov | Director | 5,000 | $2.45 | $12.2K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| ROSENWALD LINDSAY A MD | CEO | $6.4M | $0 | 2024-09-23 |
| WEISS MICHAEL S | Director | $1.3M | $0 | 2023-11-14 |
| LOBELL J JAY | Director | $251.5K | $0 | 2023-02-10 |
| Jin David | CFO | $33.0K | $0 | 2023-02-10 |
| Klein Dov | Director | $0 | $31.2K | 2024-05-20 |
| Lu Lucy | Director | $10.1K | $0 | 2023-02-10 |
| Rowinsky Eric K | Director | $10.1K | $0 | 2023-02-10 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2023-02-10 | 6 | $3.3M | 60 | +7.5% (+2.9% raw) | -1.8% (-0.3% raw) | -47.5% (-40.3% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.